Incyte (INCY) shares soared 5.5% in the last trading session to close at $102.69. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...

Incyte Corporation (NASDAQ:INCY) Q2 2025 Earnings Call Transcript July 29, 2025 Incyte Corporation beats earnings expectations. Reported EPS is $2.04, expectations were $1.39. Operator: Greetings, and ...

Incyte INCY announced that the European Commission (EC) has approved a label expansion of Minjuvi (tafasitamab). The drug, in combination with Revlimid (lenalidomide) and rituximab, is now indicated ...

Baker Brothers’ Q3 2025 13F portfolio rose to $13.84B, with high concentration in BeOne Medicines, Incyte, Madrigal Pharma, Insmed, and ACADIA Pharma. INCY, now ~19% of the portfolio, saw a marginal ...